EquityFlow › Companies › SERDA Therapeutics

SERDA Therapeutics

Biotech · Amsterdam, NL

Developer of enzymatic wound-debridement products.

Funding history

DateRoundAmount
Jun 2024Funding round
SERDA Therapeutics, an Amsterdam wound-care biotech JV, raised EUR2M led by NLC Health Impact Fund.
$2.2M

Investors

NLC Health Impact Fund

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →